Health Innovation Next Generation Payment & Pricing Models (HI-PRIX)

健康创新下一代支付

• 批准号: 10058086
• 金额: $ 54.8万
• 依托单位: IMPERIAL COLLEGE LONDON
• 依托单位国家: 英国
• 项目类别: EU-Funded
• 财政年份: 2023
• 资助国家: 英国
• 起止时间: 2023 至 无数据
• 项目状态: 未结题
• 来源: https://gtr.ukri.org/projects?ref=10058086
• 关键词: Health; Innovation; Next; Generation; Payment

The variety of innovative technologies with the potential to revolutionize the delivery of health care means that the policy toolbox will need several pricing and payment models, adapted in their design and implementation according to the specific situation. Although there are examples of novel pricing and payment models, the lack of appropriate data infrastructure, legal barriers and unwillingness to adapt current systems often prevent their use. Therefore, the overall objectives of the Health Innovation Next Generation Pricing Models (HI – PRIX) project are: i) to map and formulate new pricing and payment schemes that can be used across technology classes, therapeutic areas, setting and healthcare systems/geographies together with a related set of principles that may guide successful adjustment and flexible implementation to the context of use; ii) to investigate the impact on competitiveness, innovation, equity and affordability of a pipeline of contracting modalities for health innovations; iii) to address the challenges and concerns of payers, manufacturers, healthcare professionals, and patients about different models of pricing by sustaining an effective dialogue across stakeholders’ groups about the trade-offs between affordability, innovation and patient access. Coordinated by Bocconi University, the HI-PRIX Consortium involves 18 partners from 10 European countries, including academic institutions, public authorities, healthcare providers, and independent research organizations. Through theoretical models, quantitative simulation, qualitative research work and case-studies, this three-year project structured around 10 WPs, will generate new evidence on the role of public sector in R&D and indirect medical and environmental costs in pricing and reimbursement determinations, on the pricing dynamics over pharmaceutical products’ lifecycle, on the impact of policies and incentives on the competitiveness, innovativeness and equity in the healthcare system.

各种创新技术有可能彻底改变医疗保健的提供方式，这意味着政策工具箱将需要多种定价和支付模式，并根据具体情况进行设计和实施，尽管有一些新颖的定价和支付模式的例子。缺乏适当的数据基础设施、法律障碍和不愿意适应当前系统往往会阻碍其使用，因此，健康创新下一代定价模型（HI – PRIX）项目的总体目标是：i）绘制和制定新的定价。以及可跨技术使用的支付方案类别、治疗领域、环境和医疗保健系统/地域以及一套相关原则，可指导根据使用情况进行成功调整和灵活实施 ii) 调查一系列产品对竞争力、创新、公平和可负担性的影响；健康创新的合同模式；iii) 通过在利益相关者群体之间就负担能力、创新和患者获取之间的权衡进行有效对话，解决付款人、制造商、医疗保健专业人员和患者对不同定价模式的挑战和担忧。 HI-PRIX 联盟由博科尼大学协调，涉及来自 10 个欧洲国家的 18 个合作伙伴，包括学术机构、公共当局、医疗保健提供者和独立研究组织，这三个联盟通过理论模型、定量模拟、定性研究工作和案例研究。该项目为期一年，分为 10 个工作组，将产生新的证据，说明公共部门在研发中的作用以及定价和报销决定中的间接医疗和环境成本、药品生命周期的定价动态以及影响关于医疗保健系统的竞争力、创新性和公平性的政策和激励措施。